
Small-cap stock soars 76% in 1 year; Motilal Oswal sees 26% more upside— a potential multibagger in the making?
Small-cap stock: Blue Jet Healthcare share price jumped over 6 per cent in intraday trade on the BSE on Wednesday, April 30, looking set to snap its three-day losing run after domestic brokerage firm Motilal Oswal Financial Services initiated coverage on the stock with a buy recommendation, suggesting the potential for multibagger returns. The small-cap stock opened at ₹ 690 against its previous close of ₹ 686.70 and rose over 6 per cent to an intraday high of ₹ 729.25. Around 11 AM, Blue Jet Healthcare share price traded 5.61 per cent higher at ₹ 725.20. Equity benchmark Sensex was flat at 80,293 at that time.
Blue Jet Healthcare share price has been on a roll over the last year, surging 76 per cent as of April 29 close.
Shares of Blue Jet Healthcare debuted on the Indian stock exchanges on November 1, 2023. In just about a year and a half, the stock has rallied 98.5 per cent from its issue price of ₹ 346. Based on today's high of ₹ 729.25, it has more than doubled investors' money, delivering multibagger returns of 111 per cent.
The small-cap stock recently hit its 52-week high of ₹ 968.75 on March 21 this year, whereas it hit a 52-week low of ₹ 346.70 on June 4 last year.
However, it has seen selling pressure in April. As of the previous session's close, the stock has suffered a loss of 22 per cent this month and is set to snap its five-month winning streak.
Despite stellar gains over the last year, domestic brokerage firm Motilal Oswal Financial Services believes the stock has more room to grow.
The brokerage firm has initiated coverage on the stock with a 'buy' recommendation. Motilal has given a target price of ₹ 865, implying a 26 per cent upside potential from the stock's April 29 close.
"With its niche product offerings in contrast media and pharmaceutical intermediaries and API (active pharmaceutical ingredient), Blue Jet Healthcare has been changing how the healthcare industry caters to the therapeutic needs of patients around the globe," Motilal Oswal noted.
"The company has established itself as a reliable supplier to its customers for the past three decades and is now working toward moving up the value chain by significantly increasing its investment in R&D (research and development)," the brokerage firm added.
Motilal said Blue Jet Healthcare's revenue growth will be driven by new products in iodinated and gadolinium contrast media, NCE intermediates, and a high-intensity sweetener variant.
The brokerage firm also said the PI/API segment is set for strong growth, with a ramp-up in supplies for Esperion's Bempedoic acid in the coming quarters.
Taking note of the existing products ramping up and new product launches, Motilal Oswal expects Blue Jet Healthcare to post a CAGR of nearly 27 per cent, 24 per cent and 19 per cent in revenues, EBITDA and PAT, respectively, over FY25-27E.
Motilal also expects a sharp uptick in the pharma Intermediaries segment, and an average EBITDAM of 35.1 per cent during FY25-27E.
On the valuation front, according to Motilal Oswal, the stock is trading at a PE (price-to-earnings) of nearly 28 times on FY27E EPS (earnings per share) of ₹ 24.7 and FY27E EV/ EBITDA (enterprise value to earnings before interest, taxes, depreciation and amortisation) of nearly 20 times.
Read all market-related news here
Read more stories by Nishant Kumar
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
10 minutes ago
- Time of India
A riveting, action-packed year awaits Modi 3.0 on the diplomatic front
The first year of Modi 3.0 will be remembered most for Operation Sindoor, thrusting Pakistan back to the centrestage of Indian foreign policy. By striking terrorist infrastructure deep inside Pakistan, India not only imposed unprecedented costs upon Islamabad for its support to cross-border terrorism but also raised the stakes for the international community's indulgence of Pakistan's duplicity in addressing a core Indian concern. The year also saw milestones being delivered like the India-UK FTA and the India-EU end-of-2025 deadline set by both sides for a similar agreement that the EU has described as the largest deal of its kind anywhere in the world. PM Modi's visit to the US within a month of President Trump's return to the White House, along with the launch of negotiations for a bilateral trade agreement, was also one of the high points. There were other foreign policy pluses, none perhaps more significant than the breakthrough with China in the form of the successful settlement of the five-year-old border standoff. The thaw in the relationship after the Modi-Xi meeting in Oct in Russia saw India resuming bilateral visits to Beijing and agreeing on a host of measures to normalise ties. Among the highlights was the upgrade in ties with the Taliban with the first political contact in the form of external affairs minister S Jaishankar's talks with the acting Afghan foreign minister, Amir Khan Muttaqi. Modi also garnered international attention for his back-to-back visits to Russia and Ukraine, during which he stressed the importance of direct talks to end the war - something the two sides are engaged in currently. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 임플란트 고민 중이라면? 인천 시민이 주목한 33만원 시술 플란치과 더 알아보기 Undo However, many of these foreign policy hits remain an unfinished business and will test India's resolve in the days ahead. On Pakistan, the challenge will be to ensure the global community, particularly the UN Security Council where Pakistan is a member, shows understanding about the punitive terms India has set out in the 'new normal' against Pakistan-sponsored cross-border terrorism. This will be critical in the event of another terrorist attack from across the LoC. The all-party delegations have made a beginning but there's more to be done, while being mindful of the risks of India-Pakistan re-hyphenation that such an exercise might entail. Managing the relationship with the US will be another pressing challenge in the second year of Modi 3.0. This has arisen unexpectedly from Trump's constant needling of India on bilateral trade and perhaps even more damaging utterances on the India-Pakistan conflict, like his use of the term mediation - a big taboo in Indian foreign policy lexicon - and his drawing an equivalence between India and Pakistan. India is hoping that not just the US but also its other Quad partners will be more liberal in their support for India on cross-border terrorism, like in the form of a joint statement when the foreign ministers and leaders meet this year. The third significant challenge in the next few months will be to decide whether it's time to reinforce the improvement in ties with Beijing by resuming direct air and normal visa services with and, more importantly, with a visit to the country by Modi for SCO summit. Despite China's ties with Pakistan acting as a deterrent, India has kept the door open for continued engagement. Modi has also shown interest in rebuilding ties with Canada by accepting his counterpart Mark Carney's delayed invitation for the G7 but this will be subject to Ottawa's handling of Khalistani separatists and also the probe into Nijjar murder that wrecked the relationship. Signs of improvement in Pakistan-Taliban ties and the proposal to expand CPEC into Afghanistan might pose a few problems too. All in all, a riveting, action-packed year is what awaits Modi 3.0.


Economic Times
13 minutes ago
- Economic Times
Gold rises on lower dollar, US-China trade uncertainty
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price


Economic Times
13 minutes ago
- Economic Times
Ganga Bath Fittings IPO listing on June 11: Here's what GMP Indicates
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price